Optimizing the Use of Novel Therapies for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) — July 10, 2026, Roanoke, VA

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Friday, July 10, 2026

Program Schedule — Eastern Time
11:30 AM – 12:00 PM — Registration and Lunch
12:00 PM – 1:00 PM — Educational Program

Location
Blue Ridge Cancer Care
2013 S Jefferson St
Roanoke, VA 24014

Meeting Room
BRCC Roanoke Clinic Conference Room  

Ann LaCasce

Faculty

Ann LaCasce

MD, MMSc

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Associate Professor, Hematology and Medical Oncology, Program Director, Dana-Farber/MGB, Fellowship in Hematology/Oncology

Registration

Sorry. This form is no longer available.

These activities are supported by educational grants from ADC Therapeutics, AstraZeneca Pharmaceuticals LP, Genentech, a member of the Roche Group, and Pfizer Inc.